Showing results (41-50 of 11,090) with videos related to

Sort By:
Pageof 1,109
JAMA Network Open|May 29, 2020
Assessment of Language and Indexing Biases Among Chinese-Sponsored Randomized Clinical TrialsYuanxi Jia, Doudou Huang, Jiajun Wen, et al.
JAMA Network Open|May 29, 2020
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical TrialFranziska Maier, Annika Spottke, Jan-Philipp Bach, et al.
JAMA Network Open|May 30, 2020
Association of State Medicaid Expansion With Hospital Community Benefit SpendingGenevieve P Kanter, Bardia Nabet, Meredith Matone, et al.
JAMA Network Open|May 30, 2020
Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative StudyNitya Bakshi, Deeksha Katoch, Cynthia B Sinha, et al.
JAMA Network Open|June 10, 2020
Association Between Steroid-Sparing Therapy and the Risk of Perianal Fistulizing Complications Among Young Patients With Crohn DiseaseJeremy Adler, Chun Chieh Lin, Samir K Gadepalli, et al.
JAMA Network Open|May 10, 2021
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical TrialNicholas Lintzeris, Adrian J Dunlop, Paul S Haber, et al.
JAMA Network Open|May 11, 2021
Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed SchizophreniaCheng-Yi Huang, Su-Chen Fang, Yu-Hsuan Joni Shao
JAMA Network Open|May 13, 2021
Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell DiseaseStéphanie Forté, Florence Blais, Mathias Castonguay, et al.
JAMA Network Open|May 6, 2021
Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington StateTheresa E Matson, David S Carrell, Jennifer F Bobb, et al.
JAMA Network Open|May 6, 2021
Nivolumab vs Pembrolizumab for Treatment of US Patients With Platinum-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Network Meta-analysis and Cost-effectiveness AnalysisRui Pei, Yin Shi, Shuhe Lv, et al.
Pageof 1,109